Gulf Pharmaceutical Industries — Capital/Financing Update 2021

Sep 4, 2021

==> picture [104 x 61] intentionally omitted <==

Form for disclosing material information

Date	05-September-2021
Name of the Listed Company	Gulf Pharmaceutical Industries P.S.C.
The Material Information	Sale of 100% ownership in Gulf Inject LLC
The expected effect of material information on the financial position and results of the company's business and operations	Expected effect on the financial position: The transaction strengthens the cash position of the company and is expected to have a positive impact on the Q3 financial results. The divestment reduces the total consolidated assets of the Group by 3-4% as at 30-June-2021. The Gulf Inject operation is a non-core business for Julphar and management does not expect a material impact on the operations of the Group. The transaction was completed in September 2021.
The financial period in which the financial impact will appear	Q3 2021.
The Name of the Authorized Signatory	Rayan Omer
Designation	Company Secretary

Julphar ﺟﻠﻔﺎر T +971 7 246 1461 اﻟﺨﻠﯿﺞ ﻟﻠﺼﻨﺎﻋﺎت اﻟﺪواﺋﯿﺔ POBox 997 Ras Al Khaimah رأس اﻟﺨﯿﻤﺔ 997 ﺻﻨﺪوق ﺑﺮﯾﺪ F +971 7 246 2462 Gulf Pharmaceutical Industries United Arab Emirates اﻹﻣﺎرات اﻟﻌﺮﺑﯿﺔ اﻟﻤﺘﺤﺪة E infor@julphar.net

==> picture [104 x 61] intentionally omitted <==

Signature and Date 05.09.2021 Company’s Seal

ﺟﻠﻔﺎر T +971 7 246 1461 اﻟﺨﻠﯿﺞ ﻟﻠﺼﻨﺎﻋﺎت اﻟﺪواﺋﯿﺔ رأس اﻟﺨﯿﻤﺔ 997 ﺻﻨﺪوق ﺑﺮﯾﺪ F +971 7 246 2462 Gulf Pharmaceutical Industries اﻹﻣﺎرات اﻟﻌﺮﺑﯿﺔ اﻟﻤﺘﺤﺪة E infor@julphar.net

Julphar POBox 997 Ras Al Khaimah United Arab Emirates